Onychomycosis – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:16:01 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Onychomycosis – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effect of Ciclopirox in Treating Nail Fungal Infection in Patients https://clinicaltrials.eu/trial/study-on-the-effect-of-ciclopirox-in-treating-nail-fungal-infection-in-patients/ Wed, 29 Apr 2026 15:04:50 +0000 https://clinicaltrials.eu/trial/study-on-the-effect-of-ciclopirox-in-treating-nail-fungal-infection-in-patients/ This clinical trial focuses on studying the effects of a treatment for onychomycosis, which is a fungal infection of the nails. The treatment being tested is called DexULac, a medicated nail lacquer containing the active substance ciclopirox. The purpose of the study is to observe how this treatment affects the severity of the nail infection and the quality of life of those affected.

Participants in the study will apply the DexULac nail lacquer to the affected nails over a period of 48 weeks. Throughout the study, the progress of the nail infection will be monitored at various intervals to see how the condition changes over time. Additionally, the study will assess how the treatment impacts the participants’ quality of life, as living with nail infections can sometimes affect daily activities and self-esteem.

The study will also evaluate the safety of the treatment by keeping track of any side effects or adverse reactions that may occur during the 48-week treatment period. The goal is to determine not only the effectiveness of DexULac in treating onychomycosis but also to ensure that it is safe for use by patients. Participants will be regularly checked to ensure their well-being and to gather data on the treatment’s impact on their nail health and overall quality of life.

]]>